Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-045718

Director acquired 7,576 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Greene Barry E · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-11 Exercise or conversion : show line 1 in the form +7,576 $1.49 $11,250 13,606 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-11 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −7,576 0 D
Loading xslF345X03/doc4.xml…